Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering smooth muscle cell heterogeneity in atherosclerotic plaques and constructing model: a multi-omics approach with focus on KLF15/IGFBP4 axis. | BMC Genomics | 2024 | 38760675 | PubTator, text mining | PubMed |
Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification. | Front Immunol | 2024 | 38742112 | PubTator, text mining | PubMed |
| Rosmarinic acid alleviates toosendanin-induced liver injury through restoration of autophagic flux and lysosomal function by activating JAK2/STAT3/CTSC pathway. | J Ethnopharmacol | 2024 | 38631488 | PubTator, text mining | PubMed |
| DataMesh+: A Blockchain-Powered Peer-to-Peer Data Exchange Model for Self-Sovereign Data Marketplaces. | Sensors (Basel) | 2024 | 38544159 | PubTator, text mining | PubMed |
| The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583. | ERJ Open Res | 2024 | 38529344 | PubTator, text mining | PubMed |
| Regulation of Epithelial and Endothelial Barriers by Molecular Chaperones. | Cells | 2024 | 38474334 | PubTator, text mining | PubMed |
| Toosendanin induces hepatotoxicity by restraining autophagy and lysosomal function through inhibiting STAT3/CTSC axis. | Toxicol Lett | 2024 | 38460807 | PubTator, text mining | PubMed |
| Mendelian Randomization Validates the Immune Landscape Mediated by Aggrephagy in Esophageal Squamous Cell Carcinoma Patients from the Perspectives of Multi-omics. | J Cancer | 2024 | 38434988 | PubTator, text mining | PubMed |
| The Biocatalytic Potential of Aromatic Ammonia-Lyase from Loktanella atrilutea. | Chembiochem | 2024 | 38415939 | PubTator, text mining | PubMed |
| Ca 2+ -sensor ALG-2 engages ESCRTs to enhance lysosomal membrane resilience to osmotic stress. | bioRxiv | 2024 | 38352356 | PubTator, text mining | PubMed |
| FSGS Recurrence Collaboration: Report of a Symposium. | Glomerular Dis | 2024 | 38348154 | PubTator, text mining | PubMed |
| Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy. | Front Endocrinol (Lausanne) | 2024 | 38332893 | PubTator, text mining | PubMed |
| Cathepsin C regulates tumor progression via the Yes-associated protein signaling pathway in non-small cell lung cancer. | Am J Cancer Res | 2024 | 38323275 | PubTator, text mining | PubMed |
| Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens. | Genome Biol | 2024 | 38308274 | PubTator, text mining | PubMed |
| The oral microbiome of a family including Papillon-Lefèvre-syndrome patients and clinically healthy members. | BMC Oral Health | 2024 | 38297252 | PubTator, text mining | PubMed |
| Cultures of Human Skin Mast Cells, an Attractive In Vitro Model for Studies of Human Mast Cell Biology. | Cells | 2024 | 38201301 | PubTator, text mining | PubMed |
| Association between spinal manipulative therapy and lumbar spine reoperation after discectomy: a retrospective cohort study. | BMC Musculoskelet Disord | 2024 | 38200469 | PubTator, text mining | PubMed |
| Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness. | Circ Res | 2024 | 38179698 | PubTator, text mining | PubMed |
| Integrated analysis of miRNA-mRNA expression of newly emerging swine H3N2 influenza virus cross-species infection with tree shrews. | Virol J | 2024 | 38178220 | PubTator, text mining | PubMed |
| BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination. | Nat Commun | 2024 | 38167829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=10